Literature DB >> 7515587

Endothelium-dependent relaxations to adenosine in juvenile rabbit pulmonary arteries and veins.

R H Steinhorn1, F C Morin, D G Van Wylen, S F Gugino, E C Giese, J A Russell.   

Abstract

We studied the actions of adenosine and its analogues 5'-(N-ethylcarboxamido)-adenosine (NECA) and N6-cyclohexyladenosine (CHA) in pulmonary vessels isolated from juvenile rabbits. Pulmonary arteries relaxed in a concentration-dependent fashion to all three compounds. Pretreatment with the methylxanthine 8-p-sulfophenyltheophylline shifted the concentration-response curves to adenosine and NECA rightward, indicating that the vasodilator effects were mediated by the adenosine receptor. The order of potency of adenosine compounds was NECA > adenosine > CHA, indicating that the A2-receptor mediates relaxations to adenosine in rabbit pulmonary arteries. Endothelium rubbing attenuated relaxations to adenosine at concentrations of < or = 3 x 10(-7) M and to all NECA concentrations. Inhibition of nitric oxide synthase with NG-nitro-L-arginine (L-NNA) similarly attenuated relaxations at concentrations of < or = 3 x 10(-7) M for adenosine and < or = 3 x 10(-8) M for NECA. With the use of the same methods, a substantial endothelial contribution was additionally observed in pulmonary veins to the vasodilator effects of NECA. We conclude that adenosine, and the more specific A2-receptor agonist NECA, dilate pulmonary arteries and veins isolated from young rabbits via a mechanism that is partially dependent on endothelium-derived nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515587     DOI: 10.1152/ajpheart.1994.266.5.H2001

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  Unique aspects of the developing lung circulation: structural development and regulation of vasomotor tone.

Authors:  Yuangsheng Gao; David N Cornfield; Kurt R Stenmark; Bernard Thébaud; Steven H Abman; J Usha Raj
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

2.  Activation of A2-purinoceptors by adenosine stimulates L-arginine transport (system y+) and nitric oxide synthesis in human fetal endothelial cells.

Authors:  L Sobrevia; D L Yudilevich; G E Mann
Journal:  J Physiol       Date:  1997-02-15       Impact factor: 5.182

Review 3.  Phosphodiesterases: emerging therapeutic targets for neonatal pulmonary hypertension.

Authors:  Kathryn N Farrow; Robin H Steinhorn
Journal:  Handb Exp Pharmacol       Date:  2011

4.  Update on PPHN: mechanisms and treatment.

Authors:  Jayasree Nair; Satyan Lakshminrusimha
Journal:  Semin Perinatol       Date:  2014-03       Impact factor: 3.300

5.  Vascular impairment of adenosinergic system in hypertension: increased adenosine bioavailability and differential distribution of adenosine receptors and nucleoside transporters.

Authors:  Ana Sousa-Oliveira; Ana Brandão; Martin Vojtek; Salomé Gonçalves-Monteiro; Joana B Sousa; Carmen Diniz
Journal:  Histochem Cell Biol       Date:  2018-10-24       Impact factor: 4.304

6.  Effect of inhaled nitric oxide on intrapulmonary right-to-left-shunting in two rabbit models of saline lavage induced surfactant deficiency and meconium instillation.

Authors:  M F Krause; H G Lienhart; J Haberstroh; T Hoehn; J Schulte-Mönting; J U Leititis
Journal:  Eur J Pediatr       Date:  1998-05       Impact factor: 3.183

7.  Combined contribution of endothelial relaxing autacoides in the rat femoral artery response to CPCA: an adenosine A2 receptor agonist.

Authors:  Miroslav Radenković; Marko Stojanović; Radmila Janković; Mirko Topalović; Milica Stojiljković
Journal:  ScientificWorldJournal       Date:  2012-04-19

8.  Persistent pulmonary hypertension of the newborn.

Authors:  Vinay Sharma; Sara Berkelhamer; Satyan Lakshminrusimha
Journal:  Matern Health Neonatol Perinatol       Date:  2015-06-03

Review 9.  Cognitive impact of COVID-19: looking beyond the short term.

Authors:  Scott Miners; Patrick G Kehoe; Seth Love
Journal:  Alzheimers Res Ther       Date:  2020-12-30       Impact factor: 6.982

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.